13F-HR filed by Frazier Life Sciences Management, L.P.
Frazier Life Sciences Management, L.P. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-10, with 41 holding rows worth $1,059,640,000.
- Accession
- 0001420506-22-001455
- Filer
- CIK 1892134
- Filed
- 2022-08-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 41 entries on the cover page, a total value of $1,059,640,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,059,640,000 with VALUE read as thousands by filing date, 13F file number 028-22504. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 8,434,232 | $179,733,000 | thousands by filing date | |
| HILLEVAX INC | 43157M102 | COM | 9,285,682 | $101,493,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 1,095,407 | $71,924,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 3,566,912 | $69,412,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 3,595,026 | $62,877,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 3,195,403 | $61,480,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 5,827,415 | $49,183,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 870,636 | $47,876,000 | thousands by filing date | |
| IMAGO BIOSCIENCES INC | 45250K107 | COM | 2,971,274 | $39,785,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,787,405 | $38,894,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,414,823 | $26,386,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,787,527 | $26,098,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 2,985,757 | $25,409,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 2,082,093 | $20,155,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,094,154 | $18,889,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 899,700 | $18,264,000 | thousands by filing date | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 3,111,551 | $17,114,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,572,192 | $15,470,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 673,979 | $15,259,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CORP UNIT EXP 120925 | G3710A121 | Stock | 1,501,000 | $14,815,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 806,267 | $14,094,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 5,237,348 | $12,674,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 285,331 | $12,010,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 5,009,219 | $11,822,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 980,302 | $11,342,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 3,746,857 | $10,604,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 203,684 | $10,543,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 881,173 | $10,442,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 1,375,065 | $9,832,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,776,479 | $9,255,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 408,329 | $5,700,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 202,260 | $5,348,000 | thousands by filing date | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,171,627 | $3,292,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 845,636 | $2,596,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 585,759 | $2,284,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 692,910 | $2,183,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 170,000 | $1,635,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 1,374,047 | $1,253,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 739,369 | $1,087,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 1,883,244 | $1,051,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637113 | SHS | 425,650 | $77,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-001455 | this filing | 2022-08-10 | acceptance time not in the bulk data set |